Confirm delete?

Bertin Bioreagent
logo

Search

Contact Us
You are here :
  • Bioreagent   /
  • Product page
  • Human Therapeutic IgG4 ELISA Kit

Human Therapeutic IgG4 ELISA Kit

  • Zoom
    Human Therapeutic IgG4 ELISA Kit
  • Human Therapeutic IgG4 ELISA Kit
Cat No: 500920
Cayman
€759.00
Price is excluding VAT and does not include packaging neither shipping

Human therapeutic antibodies have become increasingly common components of early drug discovery and development portfolios in the pharmaceutical and biotech industries. As part of preclinical toxicology assessment of these agents, they are routinely te...

More
: 96 wells

This product can only be bought through Cayman Chemical. Please contact us.

- +
SHOOTING STAR BIOREAGENT - 20

Save 10% on every orders above 750 € (VAT Excl.)

 Save 20% on every orders above 1000 € (VAT Excl.)


SHOOTING STAR BIOREAGENT - 10

Save 10% on every orders above 750 € (VAT Excl.) 

Save 20% on every orders above 1000 € (VAT Excl.)


Territorial Availability: Available through Bertin Technologies only in Europe
Technical Warning: Check the Additional Items Required section of this kit booklet to verify if UltraPure Water (Milli-Q or equivalent) is needed for this assay
Synonyms:
  • Human IgG4 Immunometric EIA Kit
Correlated keywords:
  • ELISA
  • drug
  • discovery
  • cytotoxicity
  • toxicology
  • non-human
  • primates
  • rhesus
Show more...
Product Overview:
Human therapeutic antibodies have become increasingly common components of early drug discovery and development portfolios in the pharmaceutical and biotech industries. As part of preclinical toxicology assessment of these agents, they are routinely tested in non-human primates, primarily in rhesus or cynomolgus monkeys. In order to assess the pharmacokinetics of the human antibodies in monkey serum, it is necessary to have an assay that is capable of distinguishing the experimentally-introduced human IgG from the endogenous monkey IgG. Cayman’s IgG4 (human) Pharmacokinetic ELISA Kit is an immunometric assay which can be used to measure human IgG4 in monkey or rodent plasma and serum without prior sample purification. The standard curve spans the range of 7.8-500 ng/ml, with an LLOQ of 7.8 ng/ml. The assay has been validated in serum from cynomolgus monkeys.
Human therapeutic antibodies have become increasingly common components of early drug discovery and development portfolios in the pharmaceutical and biotech industries. As part of preclinical toxicology assessment of these agents, they are routinely tested in non-human primates, primarily in rhesus or cynomolgus monkeys. In order to assess the pharmacokinetics of the human antibodies in monkey serum, it is necessary to have an assay that is capable of distinguishing the experimentally-introduced human IgG from the endogenous monkey IgG. Cayman’s IgG4 (human) Pharmacokinetic ELISA Kit is an immunometric assay which can be used to measure human IgG4 in monkey or rodent plasma and serum without prior sample purification. The standard curve spans the range of 7.8-500 ng/ml, with an LLOQ of 7.8 ng/ml. The assay has been validated in serum from cynomolgus monkeys.
Size 96 wells
Shipping wet ice
Stability Store at 4 degrees; shelf life 180 days maximum after production
Custom Code 3822000002
UNSPSC code 41116104
UN Number UN2796

Chan, A.C., and Carter, P.J. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 10 301-16 (2010).

Stubenrauch, K., Wessels, U., and Lenz, H. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodie

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : Human Therapeutic IgG4 ELISA Kit There are 4 products.